Lupus nephritis

HJ Anders, R Saxena, M Zhao, I Parodis… - Nature reviews Disease …, 2020 - nature.com
Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …

Systemic lupus erythematosus: diagnosis and clinical management

A Fava, M Petri - Journal of autoimmunity, 2019 - Elsevier
Systemic lupus erythematosus (SLE) is a worldwide chronic autoimmune disease which
may affect every organ and tissue. Genetic predisposition, environmental triggers, and the …

[HTML][HTML] The complement system and human autoimmune diseases

SL Coss, D Zhou, GT Chua, RA Aziz, RP Hoffman… - Journal of …, 2023 - Elsevier
Genetic deficiencies of early components of the classical complement activation pathway
(especially C1q, r, s, and C4) are the strongest monogenic causal factors for the prototypic …

Redefining lupus nephritis: clinical implications of pathophysiologic subtypes

F Yu, M Haas, R Glassock, MH Zhao - Nature Reviews Nephrology, 2017 - nature.com
Systemic lupus erythematosus (SLE) is associated with a broad spectrum of clinical and
immunologic manifestations, of which lupus nephritis is the most common cause of morbidity …

Clinical and immunological biomarkers for systemic lupus erythematosus

H Yu, Y Nagafuchi, K Fujio - Biomolecules, 2021 - mdpi.com
Systemic lupus erythematosus (SLE) is characterized by immune system dysfunction and is
clinically heterogeneous, exhibiting renal, dermatological, neuropsychiatric, and …

[HTML][HTML] Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

J Hartl, L Serpas, Y Wang, A Rashidfarrokhi… - Journal of Experimental …, 2021 - rupress.org
Disclosures: P. Izmirly reported personal fees from GlaxoSmithKline outside the submitted
work. JP Buyon reported personal fees from Bristol-Myers Squibb LN advisory board …

[HTML][HTML] Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …

BH Rovin, DJ Caster, DC Cattran, KL Gibson… - Kidney international, 2019 - Elsevier
In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative
brought a diverse panel of experts in glomerular diseases together to discuss the 2012 …

Autoantibodies associated with connective tissue diseases: what meaning for clinicians?

K Didier, L Bolko, D Giusti, S Toquet… - Frontiers in …, 2018 - frontiersin.org
Connective tissue diseases (CTDs) such as systemic lupus erythematosus, systemic
sclerosis, myositis, Sjögren's syndrome, and rheumatoid arthritis are systemic diseases …

Early components of the complement classical activation pathway in human systemic autoimmune diseases

KE Lintner, YL Wu, Y Yang, CH Spencer… - Frontiers in …, 2016 - frontiersin.org
The complement system consists of effector proteins, regulators, and receptors that
participate in host defense against pathogens. Activation of the complement system, via the …

Complement in autoimmune diseases

P Vignesh, A Rawat, M Sharma, S Singh - Clinica Chimica Acta, 2017 - Elsevier
The complement system is an ancient and evolutionary conserved element of the innate
immune mechanism. It comprises of more than 20 serum proteins most of which are …